Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine in Acute Leukemia and MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML
- Status
- COMPLETED
- Phase
- PHASE2
HCT Versus CT in Elderly AML
- Status
- TERMINATED
- Phase
- PHASE3
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2